These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35538092)

  • 1. Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data.
    Kim TH; Choi YW; Lee HW; Kang SY; Son H; Choi JH; Ahn MS; Sheen SS
    Sci Rep; 2022 May; 12(1):7646. PubMed ID: 35538092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study.
    Kim TH; Choi JH; Jeon SM; Choi YW; Kwon M; Lee HW; Kang SY; Ahn MS; Son SY; Hur H; Han SU; Sheen SS
    Gastric Cancer; 2023 Nov; 26(6):1012-1019. PubMed ID: 37648892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
    Lee YG; Lee E; Kim I; Lee KW; Kim TM; Lee SH; Kim DW; Heo DS
    Cancer Res Treat; 2015 Oct; 47(4):670-5. PubMed ID: 25672586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.
    Papaxoinis G; Kamposioras K; Germetaki T; Weaver JMJ; Stamatopoulou S; Nasralla M; Kordatou Z; Owen-Holt V; Anthoney A; Mansoor W
    Acta Oncol; 2018 Jun; 57(6):790-798. PubMed ID: 29308947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
    Mellema WW; van der Hoek D; Postmus PE; Smit EF
    Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
    Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
    Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.
    Moore RA; Adel N; Riedel E; Bhutani M; Feldman DR; Tabbara NE; Soff G; Parameswaran R; Hassoun H
    J Clin Oncol; 2011 Sep; 29(25):3466-73. PubMed ID: 21810688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy and age-related biases in non-small cell lung cancer.
    Rodriguez KA; Guitron J; Hanseman DJ; Williams V; Starnes SL
    Ann Thorac Surg; 2012 Dec; 94(6):1810-4. PubMed ID: 23103001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    Kim ES; Baran AM; Mondo EL; Rodgers TD; Nielsen GC; Dougherty DW; Pandya KJ; Rich DQ; van Wijngaarden E
    PLoS One; 2017; 12(12):e0189410. PubMed ID: 29228042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer.
    Kenmotsu H; Ohde Y; Wakuda K; Nakashima K; Omori S; Ono A; Naito T; Murakami H; Kojima H; Takahashi S; Isaka M; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):609-614. PubMed ID: 28761967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction.
    Tetzlaff ED; Correa AM; Komaki R; Swisher SG; Maru D; Ross WA; Ajani JA
    Dis Esophagus; 2008; 21(7):575-81. PubMed ID: 18459989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.
    Yue D; Xu S; Wang Q; Li X; Shen Y; Zhao H; Chen C; Mao W; Liu W; Liu J; Zhang L; Ma H; Li Q; Yang Y; Liu Y; Chen H; Wang C
    Lancet Respir Med; 2018 Nov; 6(11):863-873. PubMed ID: 30150014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Xie H; Wang H; Xu L; Li M; Peng Y; Cai X; Feng Z; Ren W; Peng Z
    Clin Lung Cancer; 2018 Nov; 19(6):484-492. PubMed ID: 30369426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
    Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
    Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
    Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
    Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
    Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
    Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
    BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.